U.S. STOCKS ON THE MOVE-Under Armour, AmerisourceBergen, Blue Apron, GNC Holdings


The Day Ahead newsletter:

The Morning News Call newsletter:

U.S. stock futures pointed to another dip at the open for Wall Street on Tuesday, halting two days of gains that had somewhat cooled investor nerves about a burgeoning market correction.

The top three NYSE percentage gainers premarket:

** GNC Holdings, up 37.2 pct

** Kadmon Holdings, up 26.4 pct

** AmerisourceBergen, up 14.9 pct

The top three NYSE percentage losers premarket:

** Owens & Minor, down 4.5 pct

** Cardinal Health, down 4.5 pct

** McKesson Corp, down 4 pct

The top three Nasdaq percentage gainers premarket:

** WMIH Corp, up 28.1 pct

** LM Funding America Inc, up 9.2 pct

** China HGS Real Estate Inc, up 7.1 pct

The top three Nasdaq percentage losers premarket:

** Dare Bioscience Inc, down 33.7 pct

** Helios And Matheson Analytics, down 22.4 pct

** Affimed Nv, down 12.2 pct

** Under Armour: up 12.4 pct premarket

Under Armour reports rise in fourth-quarter revenue

** AmerisourceBergen Corp: up 14.9 pct premarket

AmerisourceBergen: Jumps on report of Walgreens takeover interest

** Helios and Matheson Analytics: down 22.4 pct premarket

Helios and Matheson Analytics: Tumbles on proposed stock offering

** Henry Schein Inc: down 5.4 pct premarket

** Patterson Companies: down 5.7 pct premarket

Henry Schein, Patterson: FTC complaint, Amazon threat weigh

** Affimed NV: down 12.2 pct premarket

Affimed NV: Slumps on stock offering

** Weibo Corp: up 5.4 pct premarket

** Sina Corp: up 4.6 pct premarket

Weibo Corp rises on quarterly beat

** Kadmon Holdings: up 24 pct premarket

Kadmon Holdings: Up on positive trial data, Jefferies raises PT

** Blue Apron Holdings: up 10.4 pct premarket

Blue Apron: Serves up smaller loss than expected

** GNC Holdings: up 37.2 pct premarket

GNC Holdings: Surges on $300 mln investment by Chinese drugmaker

** Vipshop Holdings: up 5.7 pct premarket

Vipshop Holdings: Jumps on strong quarter

** Teva Pharmaceutical: down 2.8 pct premarket

Novartis gains U.S. approval for delayed MS drug

** Himax Technologies: down 4.6 pct premarket

Himax Technologies: Dips after Q4 revenue miss

This article appears in: World Markets , US Markets , Stocks
Referenced Symbols: ABC ,

More from Reuters


See Reuters News

Research Brokers before you trade

Want to trade FX?